Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity — A randomized trial

Metabolism: Clinical and Experimental

Volumn 78, Issue , 2018, Pages 128-140

  Winn, Nathan C ^a   Liu, Ying ^a   Rector, R Scott ^a,b   Parks, Elizabeth J ^a   Ibdah, Jamal A ^b   Kanaley, Jill A ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Hepatic steatosis; High intensity interval training; Moderate intensity continuous training; Nonalcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; CYTOKERATIN 18; FATTY ACID; FETUIN A; GLUCOSE; INSULIN;

ABDOMINAL OBESITY; ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; EXERCISE; HIGH INTENSITY INTERVAL TRAINING; HUMAN; INTRAPERITONEAL FAT; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIVER FUNCTION; MIDDLE AGED; MODERATE INTENSITY CONTINUOUS EXERCISE TRAINING; NONALCOHOLIC FATTY LIVER; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TEST MEAL; ENERGY METABOLISM; FEMALE; MALE; METABOLISM; OBESITY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

ADIPOSITY; ADULT; BODY MASS INDEX; C-PEPTIDE; ENERGY METABOLISM; EXERCISE; FEMALE; GLUCOSE; HIGH-INTENSITY INTERVAL TRAINING; HUMANS; INSULIN; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, ABDOMINAL; OXYGEN CONSUMPTION; RISK FACTORS;

EID: 85032881057     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2017.08.012     Document Type: Article

References (57)

1. Stefan, N., Kantartzis, K., Haring, H.U., Causes and metabolic consequences of fatty liver. Endocr Rev 29 (2008), 939–960.
2. Musso, G., Gambino, R., Cassader, M., Pagano, G., Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43 (2011), 617–649.
3. Korenblat, K.M., Fabbrini, E., Mohammed, B.S., Klein, S., Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134 (2008), 1369–1375.
4. Fabbrini, E., Mohammed, B.S., Magkos, F., Korenblat, K.M., Patterson, B.W., Klein, S., Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134 (2008), 424–431.
5. Fracanzani, A.L., Tiraboschi, S., Pisano, G., Consonni, D., Baragetti, A., Bertelli, C., et al. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up. Atherosclerosis 246 (2016), 208–213.
6. Fargion, S., Porzio, M., Fracanzani, A.L., Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World J Gastroenterol 20 (2014), 13306–13324.
7. Kim, D., Kim, W.R., Kim, H.J., Therneau, T.M., Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 57 (2013), 1357–1365.
8. Rector, R.S., Thyfault, J.P., Morris, R.T., Laye, M.J., Borengasser, S.J., Booth, F.W., et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 294 (2008), G619–26.
9. Rector, R.S., Uptergrove, G.M., Morris, E.M., Borengasser, S.J., Laughlin, M.H., Booth, F.W., et al. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300 (2011), G874–83.
10. Linden, M.A., Fletcher, J.A., Morris, E.M., Meers, G.M., Kearney, M.L., Crissey, J.M., et al. Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. Am J Physiol Endocrinol Metab 306 (2014), E300–10.
11. Linden, M.A., Sheldon, R.D., Meers, G.M., Ortinau, L.C., Morris, E.M., Booth, F.W., et al. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis. J Physiol 594 (2016), 5271–5284.
12. Linden, M.A., Fletcher, J.A., Morris, E.M., Meers, G.M., Laughlin, M.H., Booth, F.W., et al. Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training. Med Sci Sports Exerc 47 (2015), 556–567.
13. Botezelli, J.D., Mora, R.F., Dalia, R.A., Moura, L.P., Cambri, L.T., Ghezzi, A.C., et al. Exercise counteracts fatty liver disease in rats fed on fructose-rich diet. Lipids Health Dis, 9, 2010, 116.
14. Schultz, A., Mendonca, L.S., Aguila, M.B., Mandarim-de-Lacerda, C.A., Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease. Exp Toxicol Pathol 64 (2012), 273–282.
15. Marques, C.M., Motta, V.F., Torres, T.S., Aguila, M.B., Mandarim-de-Lacerda, C.A., Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J Med Biol Res 43 (2010), 467–475.
16. Brouwers, B., Hesselink, M.K., Schrauwen, P., Schrauwen-Hinderling, V.B., Effects of exercise training on intrahepatic lipid content in humans. Diabetologia 59 (2016), 2068–2079.
17. Sullivan, S., Kirk, E.P., Mittendorfer, B., Patterson, B.W., Klein, S., Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55 (2012), 1738–1745.
18. Johnson, N.A., Sachinwalla, T., Walton, D.W., Smith, K., Armstrong, A., Thompson, M.W., et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50 (2009), 1105–1112.
19. Mahady, S.E., George, J., Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism 65 (2016), 1172–1182.
20. Hallsworth, K., Thoma, C., Hollingsworth, K.G., Cassidy, S., Anstee, Q.M., Day, C.P., et al. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci 129 (2015), 1097–1105.
21. Kapravelou, G., Martinez, R., Andrade, A.M., Nebot, E., Camiletti-Moiron, D., Aparicio, V.A., et al. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats. Appl Physiol Nutr Metab 40 (2015), 1242–1252.
22. Cho, J., Kim, S., Lee, S., Kang, H., Effect of training intensity on nonalcoholic fatty liver disease. Med Sci Sports Exerc 47 (2015), 1624–1634.
23. Craig, C.L., Marshall, A.L., Sjostrom, M., Bauman, A.E., Booth, M.L., Ainsworth, B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35 (2003), 1381–1395.
24. Szczepaniak, L.S., Nurenberg, P., Leonard, D., Browning, J.D., Reingold, J.S., Grundy, S., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005), E462–8.
25. Kanaley, J.A., Heden, T.D., Liu, Y., Whaley-Connell, A.T., Chockalingam, A., Dellsperger, K.C., et al. Short-term aerobic exercise training increases postprandial pancreatic polypeptide but not peptide YY concentrations in obese individuals. Int J Obes (Lond) 38 (2014), 266–271.
26. Nyhoff, L.M., Heden, T.D., Leidy, H.J., Winn, N.C., Park, Y.M., Thyfault, J.P., et al. Prior exercise does not alter the incretin response to a subsequent meal in obese women. Peptides 71 (2015), 94–99.
27. Weir, J.B., New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109 (1949), 1–9.
28. Kanaley, J.A., Sames, C., Swisher, L., Swick, A.G., Ploutz-Snyder, L.L., Steppan, C.M., et al. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism 50 (2001), 976–982.
29. Naressi, A., Couturier, C., Devos, J.M., Janssen, M., Mangeat, C., de Beer, R., et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 12 (2001), 141–152.
30. Rynders, C.A., Weltman, J.Y., Malin, S.K., Jiang, B., Breton, M., Barrett, E.J., et al. Comparing simple insulin sensitivity indices to the oral minimal model postexercise. Med Sci Sports Exerc 48 (2016), 66–72.
31. Solomon, T.P., Malin, S.K., Karstoft, K., Knudsen, S.H., Haus, J.M., Laye, M.J., et al. Determining pancreatic beta-cell compensation for changing insulin sensitivity using an oral glucose tolerance test. Am J Physiol Endocrinol Metab 307 (2014), E822–9.
32. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
33. Lomonaco, R., Ortiz-Lopez, C., Orsak, B., Webb, A., Hardies, J., Darland, C., et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55 (2012), 1389–1397.
34. Shah, K., Stufflebam, A., Hilton, T.N., Sinacore, D.R., Klein, S., Villareal, D.T., Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring) 17 (2009), 2162–2168.
35. Shojaee-Moradie, F., Baynes, K.C., Pentecost, C., Bell, J.D., Thomas, E.L., Jackson, N.C., et al. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50 (2007), 404–413.
36. Van Breukelen, G.J., Van Dijk, K.R., Use of covariates in randomized controlled trials. J Int Neuropsychol Soc 13 (2007), 903–904.
37. Katsagoni, C.N., Georgoulis, M., Papatheodoridis, G.V., Panagiotakos, D.B., Kontogianni, M.D., Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: a meta-analysis. Metabolism 68 (2017), 119–132.
38. Kistler, K.D., Brunt, E.M., Clark, J.M., Diehl, A.M., Sallis, J.F., Schwimmer, J.B., et al. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 106 (2011), 460–468 [quiz 9].
39. Haskell, W.L., Lee, I.M., Pate, R.R., Powell, K.E., Blair, S.N., Franklin, B.A., et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116 (2007), 1081–1093.
40. Keating, S.E., Hackett, D.A., Parker, H.M., O'Connor, H.T., Gerofi, J.A., Sainsbury, A., et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol 63 (2015), 174–182.
41. van der Heijden, G.J., Toffolo, G., Manesso, E., Sauer, P.J., Sunehag, A.L., Aerobic exercise increases peripheral and hepatic insulin sensitivity in sedentary adolescents. J Clin Endocrinol Metab 94 (2009), 4292–4299.
42. Promrat, K., Kleiner, D.E., Niemeier, H.M., Jackvony, E., Kearns, M., Wands, J.R., et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51 (2010), 121–129.
43. Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149 (2015), 367–378.e5 [quiz e14-5].
44. Zhang, H.J., He, J., Pan, L.L., Ma, Z.M., Han, C.K., Chen, C.S., et al. Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trial. JAMA Intern Med 176 (2016), 1074–1082.
45. Haus, J.M., Solomon, T.P., Kelly, K.R., Fealy, C.E., Kullman, E.L., Scelsi, A.R., et al. Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 98 (2013), E1181–8.
46. Fealy, C.E., Haus, J.M., Solomon, T.P., Pagadala, M., Flask, C.A., McCullough, A.J., et al. Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J Appl Physiol 113 (2012), 1–6.
47. Tamimi, T.I., Elgouhari, H.M., Alkhouri, N., Yerian, L.M., Berk, M.P., Lopez, R., et al. An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J Hepatol 54 (2011), 1224–1229.
48. Malin, S.K., Mulya, A., Fealy, C.E., Haus, J.M., Pagadala, M.R., Scelsi, A.R., et al. Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. J Appl Physiol 115 (2013), 988–994.
49. Stefan, N., Hennige, A.M., Staiger, H., Machann, J., Schick, F., Krober, S.M., et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29 (2006), 853–857.
50. Cuthbertson, D.J., Shojaee-Moradie, F., Sprung, V.S., Jones, H., Pugh, C.J., Richardson, P., et al. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 130 (2016), 93–104.
51. Houghton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A.D., et al. Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial. Clin Gastroenterol Hepatol 15 (2017), 96–102 [e3].
52. Li, S., Hong, M., Tan, H.Y., Wang, N., Feng, Y., Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxid Med Cell Longev, 2016, 2016, 4234061.
53. Nassir, F., Rector, R.S., Hammoud, G.M., Ibdah, J.A., Pathogenesis and prevention of hepatic steatosis. Gastroenterol Hepatol 11 (2015), 167–175.
54. Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., Jessurun, J., Boldt, M.D., Parks, E.J., Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115 (2005), 1343–1351.
55. Petersen, K.F., Dufour, S., Savage, D.B., Bilz, S., Solomon, G., Yonemitsu, S., et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104 (2007), 12587–12594.
56. Rabol, R., Petersen, K.F., Dufour, S., Flannery, C., Shulman, G.I., Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. Proc Natl Acad Sci U S A 108 (2011), 13705–13709.
57. Sunny, N.E., Bril, F., Cusi, K., Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies. Trends Endocrinol Metab 28 (2017), 250–260.